Archive

Glucose control lowers risk of cancer in obese diabetic patients

Written by Bruce Sylvester | 18 Jan 2022

Blood glucose control is key to lowering the risk of cancer in obese persons with type 2 diabetes, researchers reported on Dec. 6, 20231 in Diabetes Care. “What… read more.

Oral contraceptive reduces risk of diabetes in women with polycystic ovary syndrome

Written by Bruce Sylvester | 28 Oct 2021

Use of combined oral contraceptives appears to significantly reduce the risk of type 2 diabetes in women with polycystic ovary syndrome (PCOS). Researchers reported this finding on Oct…. read more.

EASD 2021: Osteoporosis drug appears to lower diabetes risk

Written by Bruce Sylvester | 5 Oct 2021

Treatment with alendronate, an osteoporosis drug, appears to reduce the risk of developing type 2 diabetes, researchers reported on Sept. 26, 2021 at the annual meeting of the… read more.

Standing more may help prevent chronic diseases

Written by Charlie King | 17 Sep 2021

Insulin is a key hormone in energy metabolism and blood sugar regulation. Normal insulin function in the body may be disturbed by e.g. overweight, leading to decreased insulin… read more.

Pharmacist led Type 2 diabetes intervention reverses medication use

Written by Bruce Sylvester | 16 Sep 2021

Persons with Type 2 diabetes can, through diet and pharmacist supervision, eliminate the need for diabetes medications, researchers reported on Sept. 10, 2021 in Nature Communications. “There is… read more.

Synthetic hinge could hold key to revolutionary ‘smart’ insulin therapy

Written by Charlie King | 7 Aug 2021

For people with diabetes who are insulin dependent, glycemic control is a full-time job. But what if their medication could do the work for them — an insulin… read more.

Antidepressants may improve outcomes in persons with diabetes and depression

Written by Bruce Sylvester | 2 Aug 2021

Researchers report that patients diagnosed with both diabetes and depression who are treated with antidepressants appear to achieve a lower risk of death and of serious diabetes complications…. read more.

FDA approves Kerendia in chronic kidney disease (CKD) associated with type 2 diabetes – Bayer HealthCare

Written by Charlie King | 21 Jul 2021

Bayer announced the FDA has approved Kerendia (finerenone), a first-in-class nonsteroidal mineralocorticoid receptor antagonist (MRA) indicated to reduce the risk of sustained eGFR decline, kidney failure, cardiovascular death,… read more.

New Soliqua data shows improved blood sugar control without weight gain versus premixed insulin – Sanofi

Written by Charlie King | 9 Jul 2021

A new study of Soliqua (insulin glargine 100 Units/mL and lixisenatide, (iGlarLixi) met its two primary endpoints and all key secondary endpoints in a head-to-head comparison against premixed… read more.

Forxiga recommended for approval in the EU by CHMP for the treatment of patients with chronic kidney disease – AstraZeneca

Written by Charlie King | 7 Jul 2021

AstraZeneca’s Forxiga (dapagliflozin) has been recommended for approval in the European Union (EU) for the treatment of chronic kidney disease (CKD) in adults with and without type-2 diabetes… read more.

Tizepatide shows efficacy and safety in diabetes treatment

Written by Bruce Sylvester | 5 Jul 2021

Article by Bruce Sylvester. Investigative tirzepatide appears to improve glycaemic control and bodyweight in Type 2 diabetes patients, without raising the risk of hypoglycemia. Researchers reported these findings… read more.

Investigational 2.0 mg dose of once weekly Ozempic demonstrates superior reductions in blood sugar vs Ozempic 1.0 mg in type II diabetes – Novo Nordisk

Written by Charlie King | 4 Jul 2021

Novo Nordisk presented data showing that an investigational 2.0 mg dose of Ozempic (semaglutide) provided statistically significant and superior reductions in blood sugar (HbA1C) compared with Ozempic 1.0… read more.

« Previous 1 … 7 8 9 10 11 … 37 Next »

Archive

Subscribe for our mailing list

Follow Us